Singapore markets closed

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.22-0.31 (-2.69%)
At close: 04:00PM EDT
11.22 0.00 (0.00%)
After hours: 04:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.49B
Enterprise value 3.76B
Trailing P/E N/A
Forward P/E 16.69
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.46
Price/book (mrq)1.02
Enterprise value/revenue 1.16
Enterprise value/EBITDA 16.61

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-18.34%
S&P500 52-week change 318.96%
52-week high 315.37
52-week low 36.37
50-day moving average 310.41
200-day moving average 39.03

Share statistics

Avg vol (3-month) 31.01M
Avg vol (10-day) 3798.07k
Shares outstanding 5133.2M
Implied shares outstanding 6133.2M
Float 872.49M
% held by insiders 111.89%
% held by institutions 187.69%
Shares short (15 Jul 2024) 48.92M
Short ratio (15 Jul 2024) 48.08
Short % of float (15 Jul 2024) 48.79%
Short % of shares outstanding (15 Jul 2024) 46.70%
Shares short (prior month 14 Jun 2024) 48.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -21.45%
Operating margin (ttm)7.62%

Management effectiveness

Return on assets (ttm)3.68%
Return on equity (ttm)-38.07%

Income statement

Revenue (ttm)3.25B
Revenue per share (ttm)24.28
Quarterly revenue growth (yoy)6.40%
Gross profit (ttm)N/A
EBITDA 670.18M
Net income avi to common (ttm)-695.41M
Diluted EPS (ttm)-5.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)84.47M
Total cash per share (mrq)0.65
Total debt (mrq)2.35B
Total debt/equity (mrq)159.42%
Current ratio (mrq)1.33
Book value per share (mrq)11.31

Cash flow statement

Operating cash flow (ttm)389.45M
Levered free cash flow (ttm)98.39M